APLP-2 Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # AF3685J

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse APLP-2
Leu37-Ser624
Accession # AAH52396.2
Leu37-Ser624
Accession # AAH52396.2
Specificity
Detects mouse APLP-2 in direct ELISAs and Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant human (rh) APLP-2 is observed and less than 1% cross-reactivity with rhAPLP-1 and recombinant mouse APLP-1 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for APLP-2 Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: APLP-2
Long Name
Amyloid Beta [A4] Precursor-like Protein 2
Alternate Names
APLP2, APPH, APPL2, CDEBP, WALPLP2, YWK-II
Gene Symbol
APLP2
Additional APLP-2 Products
Product Documents for APLP-2 Antibody [Janelia Fluor® 646]
Product Specific Notices for APLP-2 Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...